WO2022263498 - SUBSTITUTED PYRAZOLE AMIDES
National phase entry:
Publication Number
WO/2022/263498
Publication Date
22.12.2022
International Application No.
PCT/EP2022/066286
International Filing Date
15.06.2022
Title **
[English]
SUBSTITUTED PYRAZOLE AMIDES
[French]
AMIDES DE PYRAZOLE SUBSTITUÉS
Applicants **
GRÜNENTHAL GMBH
Zieglerstraße 6
52078 Aachen, DE
Inventors
KRÜGER, Sebastian
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
KONETZKI, Ingo
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
SITNIKOV, Nikolay
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
YOUNG, Clint
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
HAGENDORF, Silke
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
ALEN, Jo
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
PETTERSSON, Martin
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
PEIL, Sebastian
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
DIALER, Clemens
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
MÜLBAIER, Marcel
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
WAGENER, Markus
c/o Grünenthal GmbH Zieglerstraße 6
52078 Aachen, DE
Priority Data
21179636.2
15.06.2021
EP
63/210,607
15.06.2021
US
63/273,417
29.10.2021
US
63/341,107
12.05.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2523 | |
| EPO | Filing, Examination | 8075 | |
| Japan | Filing | 594 | |
| South Korea | Filing | 673 | |
| USA | Filing, Examination | 4060 |
Total: 15925 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to compounds according to general formula (I) which act as inhibitors of NaV1.8 and can be used in the treatment of pain.[French]
La présente invention concerne des composés selon la formule générale (I) qui agissent en tant qu'inhibiteurs de NaV1.8 et peuvent être utilisés dans le traitement de la douleur.